Back to directory

Froedtert & Medical College of Wisconsin

Medical College of Wisconsin

AL Amyloidosis ATTRv ATTRwt 2 Rare Subtypes

Contact Information

Primary Contact

Anita D'Souza

Professor of Medicine

Activity level

  • Patients per year250
  • New diagnoses per year100

Multidisciplinary team

  • HematologyOn-site
  • CardiologyOn-site
  • NephrologyOn-site
  • NeurologyOn-site
  • PathologyOn-site
Other specialists
GastroenterologyHepatologyGeneticistsGenetic counsellorsNuclear medicine specialistsRadiologistsTransplant programme - heartTransplant programme - kidneyAllied health professionals (NP, PA)Palliative carePsychology / counsellingSocial work

Diagnostic capabilities

  • EchocardiographyOn-site
  • Cardiac MRI (CMR)On-site
  • Radionuclide imagingOn-site
  • Histopathology (Congo red)On-site
  • Amyloid typingThrough network partners
  • Genetic testingOn-site
  • Fat aspiration / labial gland biopsyOn-site
  • Organ biopsiesOn-site
Partner laboratories

We send biopsies to Mayo Medical Lab for mass spec typing.

Subtype expertise

  • ALYes
  • ATTRvYes
  • ATTRwtYes
  • AANo
Rare subtypes
Localised amyloidosisLeukocyte chemotactic factor 2 (ALECT2)
Referral pathways

We partner with patient organizations and large Amyloid programs (Mayo Clinic and Boston University) to recommend these programs to patients

Treatment options

  • Chemotherapy (AL)Available on-site
  • TTR stabilizersAvailable on-site
  • RNA interferenceAvailable on-site
  • Antisense oligonucleotidesAvailable on-site
  • Stem cell transplantAvailable on-site
  • Heart transplantAvailable on-site
  • Kidney transplantAvailable on-site
  • Liver transplantAvailable on-site
Other therapeutic services

CAR-T and bispecific antibody therapy for AL amyloidosis

Patient support services

Services offered
Psychosocial supportSocial workGenetic counsellingNutritional guidance (dietitian)Specialty pharmacyPatient support groupsPalliative careFinancial or access counselling
Other support services

We partner with Amyloidosis Support Groups, Inc to provide patient educational material and connect patients with advocacy and support.

Networks & telemedicine

  • Telemedicine / virtual consultationYes
  • Part of a formal amyloidosis networkYes
  • Diagnostic services for other organisationsNo

Last confirmed: 16 June 2026

Listings are self-reported by each center and have not been independently verified by the International Society of Amyloidosis (ISA). Inclusion in this directory does not constitute certification, accreditation, or endorsement by ISA.